메뉴 건너뛰기




Volumn 153, Issue 4, 2012, Pages

Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

EID: 84859110467     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.09.013     Document Type: Article
Times cited : (119)

References (14)
  • 3
    • 57949094834 scopus 로고    scopus 로고
    • Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study
    • e5
    • D.M. Brown, M. Michels, P.K. Kaiser, J.S. Heier, J.P. Sy, T. Ianchulev Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study Ophthalmology 116 1 2009 57 65 e5
    • (2009) Ophthalmology , vol.116 , Issue.1 , pp. 57-65
    • Brown, D.M.1    Michels, M.2    Kaiser, P.K.3    Heier, J.S.4    Sy, J.P.5    Ianchulev, T.6
  • 7
    • 38349122535 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: A one-year prospective study
    • Z.F. Bashshur, Z.A. Haddad, A. Schakal, R.F. Jaafar, M. Saab, B.N. Noureddin Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study Am J Ophthalmol 145 2 2008 249 256
    • (2008) Am J Ophthalmol , vol.145 , Issue.2 , pp. 249-256
    • Bashshur, Z.F.1    Haddad, Z.A.2    Schakal, A.3    Jaafar, R.F.4    Saab, M.5    Noureddin, B.N.6
  • 9
    • 33846586501 scopus 로고    scopus 로고
    • Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration
    • DOI 10.1016/j.ophtha.2006.10.045, PII S0161642006014849
    • D.S. Boyer, A.N. Antoszyk, C.C. Awh, R.B. Bhisitkul, H. Shapiro, N.R. Acharya Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 2 2007 246 252 (Pubitemid 46172497)
    • (2007) Ophthalmology , vol.114 , Issue.2 , pp. 246-252
    • Boyer, D.S.1    Antoszyk, A.N.2    Awh, C.C.3    Bhisitkul, R.B.4    Shapiro, H.5    Acharya, N.R.6
  • 10
    • 36249002808 scopus 로고    scopus 로고
    • Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results
    • P.K. Kaiser, D.M. Brown, K. Zhang Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results Am J Ophthalmol 144 6 2007 850 857
    • (2007) Am J Ophthalmol , vol.144 , Issue.6 , pp. 850-857
    • Kaiser, P.K.1    Brown, D.M.2    Zhang, K.3
  • 11
    • 60149107965 scopus 로고    scopus 로고
    • Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss
    • 233
    • L. Arias, F. Armada, J. Donate Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss Eye (Lond) 23 2 2009 326 233
    • (2009) Eye (Lond) , vol.23 , Issue.2 , pp. 326
    • Arias, L.1    Armada, F.2    Donate, J.3
  • 12
    • 70349261111 scopus 로고    scopus 로고
    • Time between symptom onset and assessment in age-related macular degeneration with subfoveal choroidal neovascularization
    • R. Schalnus, C.H. Meyer, C. Kuhli-Hattenbach, M. Luchtenberg Time between symptom onset and assessment in age-related macular degeneration with subfoveal choroidal neovascularization Ophthalmologica 224 3 2009 176 182
    • (2009) Ophthalmologica , vol.224 , Issue.3 , pp. 176-182
    • Schalnus, R.1    Meyer, C.H.2    Kuhli-Hattenbach, C.3    Luchtenberg, M.4
  • 13
    • 75149116508 scopus 로고    scopus 로고
    • Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study
    • Fong DS, Custis P, Howes J, Hsu JW. Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study. Ophthalmology; 117(2):298302.
    • Ophthalmology , vol.117 , Issue.2 , pp. 298302
    • Fong, D.S.1
  • 14
    • 70449622757 scopus 로고    scopus 로고
    • Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial
    • e1
    • M.L. Subramanian, S. Ness, G. Abedi Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial Am J Ophthalmol 148 6 2009 875 882 e1
    • (2009) Am J Ophthalmol , vol.148 , Issue.6 , pp. 875-882
    • Subramanian, M.L.1    Ness, S.2    Abedi, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.